IOL Chemicals And Pharmaceuticals has a Cash Ratio of 0.30. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
NSE:IOLCP'
s Cash Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.21 Max: 1.16
Current: 0.3
During the past 13 years, IOL Chemicals And Pharmaceuticals's highest Cash Ratio was 1.16. The lowest was 0.01. And the median was 0.21.
NSE:IOLCP's Cash Ratio is ranked worse than 66.26% of 975
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs NSE:IOLCP: 0.30
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
IOL Chemicals And Pharmaceuticals Cash Ratio Related Terms
IOL Chemicals And Pharmaceuticals Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals Cash Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Cash Ratio distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Cash Ratio of 0.30 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 43% above median its historical median of 0.21. Over the past decade, IOL Chemicals And Pharmaceuticals' Cash Ratio has ranged from 0.01 to 1.16. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #646 out of 975 companies in the Drug Manufacturers industry, placing it in the top 66.3%.
Is IOL Chemicals And Pharmaceuticals' Cash Ratio too high?
IOL Chemicals And Pharmaceuticals' current Cash Ratio of 0.30 is 43% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 1.16. The Drug Manufacturers industry median Cash Ratio is 0.61. IOL Chemicals And Pharmaceuticals' value of 0.30 is 50.8% below this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #646 out of 975 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #646 out of 975 companies for Cash Ratio. This places IOL Chemicals And Pharmaceuticals in the lower half of its industry. The industry median Cash Ratio is 0.61. IOL Chemicals And Pharmaceuticals' value of 0.30 is 50.8% below this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Cash Ratio has ranged from 0.01 to 1.16 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.61, IOL Chemicals And Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Cash Ratio of 0.30 is 50.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Cash Ratio is 0.30, which is 43% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹94.18, compared to a current price of ₹171.06 — trading 81.6% above its estimated fair value. The current Cash Ratio is 0.30, which is 43% above median its 10-year median of 0.21 and 50.8% below the Drug Manufacturers industry median of 0.61. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Cash Ratio is 0.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹171.06 is trading 81.6% above its estimated GF Value™ of ₹94.18.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
Cash Ratio: 0.30 (43% above median its 10-year median of 0.21)
GF Value™: ₹94.18 vs. price of ₹171.06 (81.6% above fair value)
Industry Position: 50.8% below the Drug Manufacturers median (#646 of 975)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Business Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
57GF Score
Get the complete analysis for NSE:IOLCP
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
